A COVID vaccine company on the S&P 500 is up 600% this year

Article

In brief
A vaccine company, not an AI name, leads the S&P 500 in 2026.
A success in a cancer vaccine trial and inclusion in the Nasdaq-100 drove the rally.
Full test results will be released on October 24. The figures are still unknown.
Read the original story A COVID vaccine company on the S&P 500 is up 600% this year by Lockridge Okoth on se.beincrypto.com

Disclaimer: Includes third-party opinions. No advice. Binance AI may be used without guarantee. See T&Cs.